Skip to main content
Erschienen in: Clinical and Experimental Medicine 4/2019

13.07.2019 | Original Article

Lag3+ regulatory T lymphocytes in critical carotid artery stenosis

verfasst von: F. Del Porto, N. Cifani, M. Proietta, T. Dezi, L. Tritapepe, S. Raffa, A. Micaloni, M. Taurino

Erschienen in: Clinical and Experimental Medicine | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate CD25+ and Lag3+ T regulatory subpopulations in patients with critical carotid artery stenosis (CAS) and Stanford-A acute aortic dissection (AAD). CD25+ and Lag3+ were measured in 36 patients affected by CAS and 24 patients with Stanford type A AAD. Based on neurological symptoms, patients affected by CAS were further divided in 25 asymptomatic (CAS-A) and 11 symptomatic (CAS-S) subjects. Twenty-five patients with traditional cardiovascular risk factors (RF), matched for age and sex, were used as control group. Interleukin (IL)-10, IL-6 and transforming growth factor-β-levels were also measured. CD25+ T cells were significantly increased in CAS-S versus CAS-A (p > 0.05), AAD (p > 0.05) and RF (p > 0.05). Moreover, a significant increase in Lag3+ Tregs was observed in CAS e CAS-S versus AAD (p < 0.05) and RF (p < 0.05), whereas no significant difference was observed between CAS-S and CAS-A. IL-6 was higher in AAD compared to the other groups. Patients with neurological symptoms display a peculiar expansion of CD25+ T cells, strongly confirming a relationship between ischemic brain damage and this regulatory subpopulation, whereas Lag3+ Tregs early distinguish CAS from AAD and probably exert protective actions against aortic wall rupture throughout their anti-inflammatory functions.
Literatur
1.
Zurück zum Zitat Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007;7:585–98.CrossRef Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007;7:585–98.CrossRef
2.
Zurück zum Zitat Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell. 2008;133:775–87.CrossRef Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell. 2008;133:775–87.CrossRef
3.
Zurück zum Zitat Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.
4.
Zurück zum Zitat Groux H, O’Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737–42.CrossRef Groux H, O’Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737–42.CrossRef
5.
Zurück zum Zitat Linterman MA, Pierson W, Lee SK, et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med. 2011;17:975–82.CrossRef Linterman MA, Pierson W, Lee SK, et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med. 2011;17:975–82.CrossRef
6.
Zurück zum Zitat Lim HW, Hillsamer P, Banham AH, et al. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol. 2005;175:4180–3.CrossRef Lim HW, Hillsamer P, Banham AH, et al. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol. 2005;175:4180–3.CrossRef
7.
Zurück zum Zitat Kim HJ, Verbinnen B, Tang X, et al. Inhibition of follicular T-helper cells by CD8+ regulatory T cells is essential for self tolerance. Nature. 2010;467:328–32.CrossRef Kim HJ, Verbinnen B, Tang X, et al. Inhibition of follicular T-helper cells by CD8+ regulatory T cells is essential for self tolerance. Nature. 2010;467:328–32.CrossRef
8.
Zurück zum Zitat Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.CrossRef Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.CrossRef
9.
Zurück zum Zitat Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science. 2007;17:627–9.CrossRef Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science. 2007;17:627–9.CrossRef
10.
Zurück zum Zitat Bacchetta R, Sartirana C, Levings MK, et al. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol. 2002;32:2237–45.CrossRef Bacchetta R, Sartirana C, Levings MK, et al. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol. 2002;32:2237–45.CrossRef
11.
Zurück zum Zitat Gagliani N, Magnani CF, Huber S, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med. 2013;19:739–46.CrossRef Gagliani N, Magnani CF, Huber S, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med. 2013;19:739–46.CrossRef
12.
Zurück zum Zitat Okamura T, Fujio K, Shibuya M, et al. CD4+ CD25− LAG3+ regulatory T cells controlled by the transcription factor Egr-2. Proc Natl Acad Sci USA. 2009;106:13974–9.CrossRef Okamura T, Fujio K, Shibuya M, et al. CD4+ CD25 LAG3+ regulatory T cells controlled by the transcription factor Egr-2. Proc Natl Acad Sci USA. 2009;106:13974–9.CrossRef
13.
Zurück zum Zitat Okamura T, Sumitomo S, Morita K, et al. TGF-β3-expressing CD4+ CD25− LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329.CrossRef Okamura T, Sumitomo S, Morita K, et al. TGF-β3-expressing CD4+ CD25 LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329.CrossRef
14.
Zurück zum Zitat Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13:368–80.CrossRef Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13:368–80.CrossRef
15.
Zurück zum Zitat Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013;121:679–91.CrossRef Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013;121:679–91.CrossRef
16.
Zurück zum Zitat Del Porto F, Cifani N, Proietta M, et al. Regulatory T CD4+ CD25+ lymphocytes increase in symptomatic carotid artery stenosis. Ann Med. 2017;49:283–90.CrossRef Del Porto F, Cifani N, Proietta M, et al. Regulatory T CD4+ CD25+ lymphocytes increase in symptomatic carotid artery stenosis. Ann Med. 2017;49:283–90.CrossRef
17.
Zurück zum Zitat Kaplan A, Altara R, Eid A, et al. Update on the protective role of regulatory T Cells in myocardial infarction: a promising therapy to repair the heart. J Cardiovasc Pharmacol. 2016;68:401–13.CrossRef Kaplan A, Altara R, Eid A, et al. Update on the protective role of regulatory T Cells in myocardial infarction: a promising therapy to repair the heart. J Cardiovasc Pharmacol. 2016;68:401–13.CrossRef
18.
Zurück zum Zitat Raman G, Moorthy D, Hadar N, et al. Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis. Ann Intern Med. 2013;158:676–85.CrossRef Raman G, Moorthy D, Hadar N, et al. Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis. Ann Intern Med. 2013;158:676–85.CrossRef
19.
Zurück zum Zitat Kidwell CS, Warach S. Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke. 2003;34:2995–8.CrossRef Kidwell CS, Warach S. Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke. 2003;34:2995–8.CrossRef
20.
Zurück zum Zitat Nakachi S, Sumitomo S, Tsuchida Y, et al. Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis. Arthritis Res Ther. 2017;19:97.CrossRef Nakachi S, Sumitomo S, Tsuchida Y, et al. Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis. Arthritis Res Ther. 2017;19:97.CrossRef
21.
Zurück zum Zitat Del Porto F, Proietta M, Tritapepe L, et al. Inflammation and immune response in acute aortic dissection. Ann Med. 2010;42:622–9.CrossRef Del Porto F, Proietta M, Tritapepe L, et al. Inflammation and immune response in acute aortic dissection. Ann Med. 2010;42:622–9.CrossRef
Metadaten
Titel
Lag3+ regulatory T lymphocytes in critical carotid artery stenosis
verfasst von
F. Del Porto
N. Cifani
M. Proietta
T. Dezi
L. Tritapepe
S. Raffa
A. Micaloni
M. Taurino
Publikationsdatum
13.07.2019
Verlag
Springer International Publishing
Erschienen in
Clinical and Experimental Medicine / Ausgabe 4/2019
Print ISSN: 1591-8890
Elektronische ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-019-00570-x

Weitere Artikel der Ausgabe 4/2019

Clinical and Experimental Medicine 4/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.